This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Community Health Down 16% in a Year: Can it Bounce Back?
by Zacks Equity Research
Community Health (CYH) suffers from high debt and low patient volumes, growth strategies is likely to restore its profitability.
Acadia Healthcare (ACHC) Misses on Q3 Earnings, Trims View
by Zacks Equity Research
Acadia Healthcare's (ACHC) Q3 earnings missed estimates and declined year over year on increase in expenses.
LifePoint Hospitals (LPNT) Q3 Earnings Surpass Estimates
by Zacks Equity Research
LifePoint (LPNT) delivered earnings and revenue surprises of 21.57% and -0.01%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
LifePoint Hospitals (LPNT) Q3 Earnings Preview: What to Look Out For
by Zacks Equity Research
LifePoint (LPNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Acadia Healthcare (ACHC) Surges: Stock Moves 7.9% Higher
by Zacks Equity Research
Acadia Healthcare (ACHC) shares rose nearly 8% in the last trading session, amid huge volumes.
Community Health's (CYH) Subsidiary to Clear Fraud Charges
by Zacks Equity Research
Community Health Systems' (CYH) arm to settle whistleblower lawsuits alleging a wide-ranging misconduct in emergency rooms.
Is LifePoint Health (LPNT) a Good Stock for Value Investors?
by Zacks Equity Research
Let's see if LifePoint Health, Inc. (LPNT) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Will Hurricane Florence Hurt LifePoint's Patient Volumes?
by Zacks Equity Research
LifePoint's (LPNT) exposure to Carolina might lead to decline in patient visits, possibly hurting business volumes.
Here's Why HCA Healthcare (HCA) Must be in Your Portfolio Now
by Zacks Equity Research
Increased earnings guidance, and strong inorganic and organic growth prospects poise HCA Healthcare (HCA) for growth.
Hospital Industry Outlook: Solid Fundamentals Promise Growth
by Zacks Equity Research
Aging population, investments in technology and a strong economy should drive the hospital industry's long-term growth
LifePoint Hospitals (LPNT) Q2 Earnings Surpass Estimates
by Zacks Equity Research
LifePoint (LPNT) delivered earnings and revenue surprises of 17.59% and -0.71%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Company News For Jul 24, 2018
by Zacks Equity Research
Companies In The News are: HAS,HAL,LPNT,ITW
Acquisitions Aid Revenue Growth at Ensign Group (ENSG)
by Zacks Equity Research
Ensign Group's (ENSG) acquisitions over several past years have driven growth.
LifePoint Health (LPNT) Up 4.3% Since Earnings Report: Can It Continue?
by Zacks Equity Research
LifePoint Health (LPNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
LifePoint Health (LPNT) Q1 Earnings Beat, Revenues Miss
by Zacks Equity Research
LifePoint's (LPNT) Q1 earnings and revenues beat on the back of an increase in same-hospital revenues per equivalent admission.
Should You Buy LifePoint Health (LPNT) Ahead of Earnings?
by Zacks Equity Research
LifePoint Health (LPNT) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.
Can Universal Health (UHS) Q1 Earnings Beat on Admissions?
by Zacks Equity Research
Universal Health's (UHS) first-quarter results are likely to outperform on the back of a solid segmental performance supported by rise in admissions, licensed beds as well as patient days.
Why Is LifePoint Health (LPNT) Down 2.9% Since its Last Earnings Report?
by Zacks Equity Research
LifePoint Health (LPNT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is LifePoint Health (LPNT) a Great Stock for Value Investors?
by Zacks Equity Research
Is LifePoint Health (LPNT) a great pick from the value investor's perspective right now? Read on to know more.
LifePoint Health (LPNT) Q4 Earnings Miss on Lower Revenues
by Zacks Equity Research
LifePoint Health (LPNT) fails to beat the earnings and revenue estimates in the fourth quarter. Equivalent admissions decline 3% year over year.
Can Solid Medicaid Business Boost Centene (CNC) Q4 Earnings?
by Zacks Equity Research
Centene's (CNC) fourth-quarter results are expected to be supported by membership growth and cost-saving initiatives.
Here's Why You Should Steer Clear of LifePoint (LPNT) Stock
by Zacks Equity Research
LifePoint (LPNT) continues to suffer due to a challenging volume environment and weak revenues.
Lower Admissions to Hurt Tenet Healthcare (THC) Q3 Earnings?
by Zacks Equity Research
Tenet Healthcare's (THC) third-quarter earnings are likely to be affected by lower revenues and higher expenses
New Strong Sell Stocks for November 2nd
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
LifePoint Health's (LPNT) Q3 Earnings and Revenues Miss
by Zacks Equity Research
LifePoint Health's (LPNT) third-quarter earnings missed estimates and declined year over year owing to lower revenues.